Paul Anderson
133 works · 6,419 citations · h-index 35
Top works
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
- L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase
- Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.
- 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side-chain ester derivatives of mevinolin
- Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260
- Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma
- The mechanism of the reduction of pyridinium ions with sodium borohydride
- Martinelline and Martinellic Acid, Novel G-Protein Linked Receptor Antagonists from the Tropical Plant Martinella iquitosensis (Bignoniaceae)
- Cyclopsychotride A, a Biologically Active, 31-Residue Cyclic Peptide Isolated from Psychotria longipes
- X-Ray Crystal Structure of the HIV Protease Complex with L-700,417, an Inhibitor with Pseudo C2 Symmetry
- Benzocycloalkyl amines as novel C-termini for HIV protease inhibitors
- X-ray crystal structure of the HIV protease complex with L-700,417, an inhibitor with pseudo C2 symmetry
- A super active cyclic hexapeptide analog of somatostatin
- Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors
- The mechanism of the reduction of pyridinium ions by sodium borohydride, II.
- Topically active carbonic anhydrase inhibitors. 2. Benzo[b]thiophenesulfonamide derivatives with ocular hypotensive activity
- Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1
- 1-(((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo[2.2.1]heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine (L-368,899): An Orally Bioavailable, Non-Peptide Oxytocin Antagonist with Potential Utility for Managing Preterm Labor
- A Structurally Unique, Potent, and Selective Oxytocin Antagonist Derived from Streptomyces silvensis
- Structure-Based Design of HIV-1 Protease Inhibitors: Replacement of Two Amides and a 10.pi.-Aromatic System by a Fused Bis-tetrahydrofuran